{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:05:10Z","timestamp":1773309910457,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bladder cancer, a common neoplasm, is primarily caused by tobacco smoking. Epigenetic alterations including DNA methylation have the potential to be used as prospective markers of increased risk, particularly in at-risk populations such as smokers. We aimed to investigate the potential of smoking-related white blood cell (WBC) methylation markers to contribute to an increase in bladder cancer risk prediction over classical questionnaire-based smoking metrics (i.e., duration, intensity, packyears) in a nested case\u2013control study within the prospective prostate, lung, colorectal, and ovarian (PLCO) Cancer Screening Trial and the alpha-tocopherol, beta-carotene cancer (ATBC) Prevention Study (789 cases; 849 controls). We identified 200 differentially methylated sites associated with smoking status and 28 significantly associated (after correction for multiple testing) with bladder cancer risk among 2670 previously reported smoking-related cytosine\u2013phosphate\u2013guanines sites (CpGs). Similar patterns were observed across cohorts. Receiver operating characteristic (ROC) analyses indicated that cg05575921 (AHHR), the strongest smoking-related association we identified for bladder cancer risk, alone yielded similar predictive performance (AUC: 0.60) than classical smoking metrics (AUC: 0.59\u20130.62). Best prediction was achieved by including the first principal component (PC1) from the 200 smoking-related CpGs alongside smoking metrics (AUC: 0.63\u20130.65). Further, PC1 remained significantly associated with elevated bladder cancer risk after adjusting for smoking metrics. These findings suggest DNA methylation profiles reflect aspects of tobacco smoke exposure in addition to those captured by smoking duration, intensity and packyears, and\/or individual susceptibility relevant to bladder cancer etiology, warranting further investigation.<\/jats:p>","DOI":"10.1007\/s10654-024-01110-y","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:01:52Z","timestamp":1711778512000},"page":"393-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-8163","authenticated-orcid":false,"given":"Roel","family":"Vermeulen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bodinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Dagnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rin","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrius","family":"Albanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Chadeau-Hyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"issue":"7","key":"1110_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737\u201345. https:\/\/doi.org\/10.1001\/jama.2011.1142.","journal-title":"JAMA"},{"issue":"4 Pt 1","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.juro.2015.10.139","volume":"195","author":"FH van Osch","year":"2016","unstructured":"van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP. Significant role of lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis. J Urol. 2016;195(4 Pt 1):872\u20139. https:\/\/doi.org\/10.1016\/j.juro.2015.10.139.","journal-title":"J Urol"},{"issue":"7","key":"1110_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10552-018-1046-8","volume":"29","author":"FHM van Osch","year":"2018","unstructured":"van Osch FHM, Jochems SHJ, Reulen RC, et al. The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study. Cancer Causes Control. 2018;29(7):675\u201383. https:\/\/doi.org\/10.1007\/s10552-018-1046-8.","journal-title":"Cancer Causes Control"},{"issue":"9","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"387.e1","DOI":"10.1016\/j.urolonc.2015.04.014","volume":"33","author":"JJ Fantony","year":"2015","unstructured":"Fantony JJ, Abern MR, Gopalakrishna A, et al. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Urol Oncol. 2015;33(9):387.e1-6. https:\/\/doi.org\/10.1016\/j.urolonc.2015.04.014.","journal-title":"Urol Oncol"},{"issue":"3","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/ede.0000000000000964","volume":"30","author":"FHM van Osch","year":"2019","unstructured":"van Osch FHM, Vlaanderen J, Jochems SHJ, et al. Modeling the complex exposure history of smoking in predicting bladder cancer: a pooled analysis of 15 case-control studies. Epidemiology. 2019;30(3):458\u201365. https:\/\/doi.org\/10.1097\/ede.0000000000000964.","journal-title":"Epidemiology"},{"issue":"12","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1158\/1055-9965.Epi-21-0313","volume":"30","author":"C Yu","year":"2021","unstructured":"Yu C, Jordahl KM, Bassett JK, et al. Smoking methylation marks for prediction of urothelial cancer risk. Cancer Epidemiol Biomarkers  Prev. 2021;30(12):2197\u2013206. https:\/\/doi.org\/10.1158\/1055-9965.Epi-21-0313.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1110_CR7","doi-asserted-by":"publisher","unstructured":"Gao X, Zhang Y, Breitling LP, Brenner H. Tobacco smoking and methylation of genes related to lung cancer development. Oncotarget. 2016;7(37):59017\u201328. https:\/\/doi.org\/10.18632\/oncotarget.10007","DOI":"10.18632\/oncotarget.10007"},{"issue":"8","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/hmg\/ddu751","volume":"24","author":"F Guida","year":"2015","unstructured":"Guida F, Sandanger TM, Castagne R, et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum Mol Genet. 2015;24(8):2349\u201359. https:\/\/doi.org\/10.1093\/hmg\/ddu751.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1110_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/circgenetics.116.001506","volume":"9","author":"R Joehanes","year":"2016","unstructured":"Joehanes R, Just AC, Marioni RE, et al. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet. 2016;9(5):436\u201347. https:\/\/doi.org\/10.1161\/circgenetics.116.001506.","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13148-020-00951-0","volume":"12","author":"SCE Maas","year":"2020","unstructured":"Maas SCE, Mens MMJ, K\u00fchnel B, et al. Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. Clin Epigenetics. 2020;12(1):157. https:\/\/doi.org\/10.1186\/s13148-020-00951-0.","journal-title":"Clin Epigenetics"},{"key":"1110_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745918","volume":"11","author":"H Tang","year":"2021","unstructured":"Tang H, Yang D, Han C, Mu P. Smoking, DNA methylation, and breast cancer: a mendelian randomization study. Front Oncol. 2021;11: 745918. https:\/\/doi.org\/10.3389\/fonc.2021.745918.","journal-title":"Front Oncol"},{"key":"1110_CR12","doi-asserted-by":"publisher","unstructured":"Jordahl KM, Phipps AI, Randolph TW, et al. Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk. BMC Med Genet. 2020;21(1):228-. https:\/\/doi.org\/10.1186\/s12881-020-01172-1","DOI":"10.1186\/s12881-020-01172-1"},{"issue":"3","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/epi.27386","volume":"9","author":"S Karami","year":"2014","unstructured":"Karami S, Pfeiffer RM, Hurwitz L, et al. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants AU - Andreotti. Gabriella Epigenetics. 2014;9(3):404\u201315. https:\/\/doi.org\/10.4161\/epi.27386.","journal-title":"Gabriella Epigenetics"},{"key":"1110_CR14","doi-asserted-by":"publisher","unstructured":"Gohagan JK, Prorok PC, Hayes RB, Kramer B-S. The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status. Control. Clin. Trials. 2000;21(6, Supplement 1):251S-72S. https:\/\/doi.org\/10.1016\/S0197-2456(00)00097-0","DOI":"10.1016\/S0197-2456(00)00097-0"},{"issue":"1","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mrfmmm.2005.06.013","volume":"592","author":"RB Hayes","year":"2005","unstructured":"Hayes RB, Sigurdson A, Moore L, et al. Methods for etiologic and early marker investigations in the PLCO trial. Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis. 2005;592(1):147\u201354. https:\/\/doi.org\/10.1016\/j.mrfmmm.2005.06.013.","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"issue":"21","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/jnci\/88.21.1560","volume":"88","author":"D Albanes","year":"1996","unstructured":"Albanes D, Heinonen O, Taylor PR, et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88(21):1560\u201370.","journal-title":"J Natl Cancer Inst"},{"key":"1110_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0064-7","author":"G Campanella","year":"2018","unstructured":"Campanella G, Gunter MJ, Polidoro S, et al. Epigenome-wide association study of adiposity and future risk of obesity-related diseases. Int J Obes. 2018. https:\/\/doi.org\/10.1038\/s41366-018-0064-7.","journal-title":"Int J Obes"},{"issue":"4","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/ije\/dyac042","volume":"51","author":"K Alcala","year":"2022","unstructured":"Alcala K, Mariosa D, Smith-Byrne K, et al. The relationship between blood pressure and risk of renal cell carcinoma. Int J Epidemiol. 2022;51(4):1317\u201327. https:\/\/doi.org\/10.1093\/ije\/dyac042.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/annonc\/mdu056","volume":"25","author":"M Chadeau-Hyam","year":"2014","unstructured":"Chadeau-Hyam M, Vermeulen RC, Hebels DG, et al. Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis. Ann Oncol. 2014;25(5):1065\u201372. https:\/\/doi.org\/10.1093\/annonc\/mdu056.","journal-title":"Ann Oncol"},{"issue":"5","key":"1110_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1289\/ehp.1002546","volume":"119","author":"CM McHale","year":"2011","unstructured":"McHale CM, Zhang LP, Lan Q, et al. Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect. 2011;119(5):628\u201334. https:\/\/doi.org\/10.1289\/ehp.1002546.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"16714","DOI":"10.1038\/s41598-018-34334-6.)","volume":"8","author":"TM Sandanger","year":"2018","unstructured":"Sandanger TM, N\u00f8st TH, Guida F, et al. DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian Women and Cancer cohort. Scientific Reports. 2018;8(1):16714. https:\/\/doi.org\/10.1038\/s41598-018-34334-6.","journal-title":"Scientific Reports."},{"key":"1110_CR22","doi-asserted-by":"publisher","first-page":"38705","DOI":"10.1038\/srep38705","volume":"6","author":"R Castagne","year":"2016","unstructured":"Castagne R, Kelly-Irving M, Campanella G, et al. Biological marks of early-life socioeconomic experience is detected in the adult inflammatory transcriptome. Sci Rep. 2016;6:38705. https:\/\/doi.org\/10.1038\/srep38705.","journal-title":"Sci Rep"},{"key":"1110_CR23","doi-asserted-by":"publisher","first-page":"25170","DOI":"10.1038\/srep25170","volume":"6","author":"R Castagne","year":"2016","unstructured":"Castagne R, Delpierre C, Kelly-Irving M, et al. A life course approach to explore the biological embedding of socioeconomic position and social mobility through circulating inflammatory markers. Sci Rep. 2016;6:25170. https:\/\/doi.org\/10.1038\/srep25170.","journal-title":"Sci Rep"},{"key":"1110_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31536","author":"R Vermeulen","year":"2018","unstructured":"Vermeulen R, Saberi Hosnijeh F, Bodinier B, et al. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: univariate and functionally informed multivariate analyses. Int J Cancer. 2018. https:\/\/doi.org\/10.1002\/ijc.31536.","journal-title":"Int J Cancer"},{"issue":"1","key":"1110_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters TJ, Buckley MJ, Statham AL, et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015;8(1):6. https:\/\/doi.org\/10.1186\/1756-8935-8-6.","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"1110_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","volume":"17","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17(6):520\u20135.","journal-title":"Bioinformatics"},{"key":"1110_CR27","doi-asserted-by":"publisher","unstructured":"Hiraki M, Nishimura J, Takahashi H, et al. Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer. Mol Ther Nucleic Acids. 2015;4(3):e231-e. https:\/\/doi.org\/10.1038\/mtna.2015.5","DOI":"10.1038\/mtna.2015.5"},{"issue":"6","key":"1110_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/bjc.2016.237","volume":"115","author":"P-A Dugu\u00e9","year":"2016","unstructured":"Dugu\u00e9 P-A, Brinkman MT, Milne RL, et al. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study. Br J Cancer. 2016;115(6):664\u201373. https:\/\/doi.org\/10.1038\/bjc.2016.237.","journal-title":"Br J Cancer"},{"key":"1110_CR29","unstructured":"Tanaka M, Tanaka T, Matsuzaki S, et al. Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers. Med Sci Monit. 2003;9(7):MT61\u20138."},{"issue":"1","key":"1110_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12885-016-2748-5","volume":"16","author":"JP Roperch","year":"2016","unstructured":"Roperch JP, Grandchamp B, Desgrandchamps F, et al. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer. BMC Cancer. 2016;16(1):704. https:\/\/doi.org\/10.1186\/s12885-016-2748-5.","journal-title":"BMC Cancer"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-024-01110-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:28:12Z","timestamp":1715938092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-024-01110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s10654-024-01110-y","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}